MFC

엠에프씨(주) · KOSDAQ · 432980 · Industry: Manufacture of medicinal chemicals

Key metrics

Earnings

Revenue, Q3 2026₩4.4bn As of Sep 30, 2026 Source 1 ↗
Revenue QoQ-26.8% As of Sep 30, 2026 Source 1 ↗, Source 2 ↗
Revenue YoY-2.7% As of Sep 30, 2026 Source 1 ↗, Source 2 ↗
Operating income, Q3 2026-₩228m As of Sep 30, 2026 Source 1 ↗
Operating income QoQTurned to loss As of Sep 30, 2026 Source 1 ↗, Source 2 ↗
Operating income YoYTurned to loss As of Sep 30, 2026 Source 1 ↗, Source 2 ↗

Share buybacks

Buyback decided, last 3 months₩1.0bn As of Nov 2, 2026 Source 1
Buyback decided, last 3 months, % of shares5.2% As of Nov 2, 2026 Source 1, Source 2 ↗
Shares acquired, last 3 months₩0 As of Nov 19, 2026
Shares acquired, last 3 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Treasury shares cancelled, last 3 months₩2.7bn As of Nov 2, 2026 Source 1 ↗
Treasury shares cancelled (number), last 3 months400,000 shares As of Nov 2, 2026 Source 1 ↗
Treasury shares cancelled, last 3 months, % of shares4.7% As of Nov 2, 2026 Source 1 ↗, Source 2 ↗
Buyback decided, last 12 months₩2.0bn As of Nov 2, 2026 Source 1 ↗, Source 2
Buyback decided, last 12 months, % of shares9.3% As of Nov 2, 2026 Source 1 ↗, Source 2, Source 3 ↗
Shares acquired, last 12 months₩1.0bn As of Aug 6, 2026 Source 1 ↗
Shares acquired, last 12 months, % of shares3.9% As of Aug 6, 2026 Source 1 ↗, Source 2 ↗
Treasury shares cancelled, last 12 months₩2.7bn As of Nov 2, 2026 Source 1 ↗
Treasury shares cancelled (number), last 12 months400,000 shares As of Nov 2, 2026 Source 1 ↗
Treasury shares cancelled, last 12 months, % of shares4.7% As of Nov 2, 2026 Source 1 ↗, Source 2 ↗

Potential dilution

CB/BW/EB issued, last 12 months₩0 As of Nov 19, 2026
Rights offering new shares, last 12 months0 shares As of Nov 19, 2026
Potential new shares, last 12 months0 shares As of Nov 19, 2026
Potential new shares, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Conversion price adjustments, last 12 months0 As of Nov 19, 2026

Supply contracts

Supply contracts, last 12 months₩0 As of Nov 19, 2026
Supply contracts vs prior-year revenue0.0% As of Nov 19, 2026
Contracts without a KRW amount0 contracts without a KRW amount excluded As of Nov 19, 2026

Disclosure activity

DART filings, last 3 months2 As of Nov 19, 2026
DART filings, previous 3 months10 As of Nov 19, 2026

Insider transactions

Open-market buys, last 12 months (shares)13,207 shares As of Jul 31, 2026 Source 1 ↗, Source 2 ↗, Source 3 ↗, Source 4 ↗, Source 5 ↗ +1 more
Open-market buys, last 12 months (amount)₩35m As of Jul 31, 2026 Source 1 ↗, Source 2 ↗, Source 3 ↗, Source 4 ↗, Source 5 ↗ +1 more
Open-market sells, last 12 months (shares)492 shares As of Jul 9, 2026 Source 1 ↗
Open-market sells, last 12 months (amount)₩1m As of Jul 9, 2026 Source 1 ↗
Net open-market buying, last 12 months (shares)12,715 shares As of Jul 31, 2026 Source 1 ↗, Source 2 ↗, Source 3 ↗, Source 4 ↗, Source 5 ↗ +2 more
Insiders who bought, last 12 months4 As of Jul 31, 2026 Source 1 ↗, Source 2 ↗, Source 3 ↗, Source 4 ↗, Source 5 ↗ +1 more

Insider transactions (last 12 months)

Open-market buys: 13,207 shares (₩35m). Open-market sells: 492 shares (₩1m). Net open-market buying: +12,715 shares. Insiders who bought: 4.

Trade dateInsider (role)TypeSharesPriceAmount
Jul 31, 2026Seo Gi-hyeong (Registered director)Open-market buy+4,598 shares₩2,524₩12m
Jul 22, 2026Lee Myeong-yun (Non-registered officer)Open-market buy+2,000 shares₩2,590₩5m
Jul 9, 2026Lee Myeong-yun (Non-registered officer)Open-market sell-492 shares₩2,820₩1m
Jun 4, 2026Hong Mun-gi (Non-registered officer)Open-market buy+907 shares₩2,597₩2m
Jun 2, 2026Hong Mun-gi (Non-registered officer)Open-market buy+535 shares₩2,633₩1m
Jun 1, 2026Hong Mun-gi (Non-registered officer)Open-market buy+833 shares₩2,623₩2m
May 29, 2026Hong Mun-gi (Non-registered officer)Open-market buy+83 shares₩2,740₩227,420
May 28, 2026Hong Mun-gi (Non-registered officer)Open-market buy+236 shares₩2,784₩657,024
May 26, 2026Hong Mun-gi (Non-registered officer)Open-market buy+456 shares₩2,821₩1m
May 22, 2026Lee In-bae (Non-registered officer)Open-market buy+1,176 shares₩2,965₩3m
May 21, 2026Lee In-bae (Non-registered officer)Open-market buy+1,183 shares₩2,831₩3m
May 20, 2026Lee In-bae (Non-registered officer)Open-market buy+1,200 shares₩2,745₩3m
Apr 1, 2026Lee In-bae (Non-registered officer)Other (New appointment)+7,777 shares₩3,500₩27m
Dec 29, 2025Lee Myeong-yun (Non-registered officer)Other (Treasury stock bonus)+492 shares₩3,475₩2m
Dec 29, 2025Park Yong-min (Non-registered officer)Other (Treasury stock bonus)+1,228 shares₩3,475₩4m
Dec 29, 2025Park Jang-ha (Registered director)Other (Treasury stock bonus)+1,289 shares₩3,475₩4m
Dec 29, 2025Park Jun-seong (Non-registered officer)Other (Treasury stock bonus)+1,572 shares₩3,475₩5m
Dec 29, 2025Choi Yeong-jae (Non-registered officer)Other (Treasury stock bonus)+1,743 shares₩3,475₩6m
Dec 29, 2025Kwon Seok-jin (Non-registered officer)Other (Treasury stock bonus)+1,522 shares₩3,475₩5m
Dec 29, 2025Seo Gi-hyeong (Registered director)Other (Treasury stock bonus)+5,402 shares₩3,475₩19m
Dec 29, 2025Jung Won-taek (Non-registered officer)Other (Treasury stock bonus)+3,118 shares₩3,475₩11m
Dec 29, 2025Hong Mun-gi (Non-registered officer)Other (Treasury stock bonus)+2,456 shares₩3,475₩9m
Dec 29, 2025Lee Jeong-ok (Non-registered officer)Other (Treasury stock bonus)+1,105 shares₩3,475₩4m

Annual financials

YearRevenueOperating income
2025₩20.8bn₩297m
2024₩20.6bn₩1.5bn

Filing timeline